•  
  •  
 

Author Credentials

Erin Reese B.S. OMS-III, Wyatt Grimm B.S OMS-III, Aaron McGuffin M.D.

Author ORCID Identifier

0009-0001-1949-8705

0009-0006-2017-2805

0009-0007-7314-8515

Keywords

infantile hemangioma; dermatology; vascular; pediatrics

Disciplines

Dermatology | Medicine and Health Sciences | Pediatrics | Skin and Connective Tissue Diseases

Abstract

Infantile hemangiomas (IH), the most prevalent infantile tumor, are benign vascular tumors arising from proliferation and dysregulation of angiogenesis. Hemangiomas are present after birth and undergo 3 stages: proliferation, plateau, and involution. IH are further categorized into superficial, deep, and mixed based on skin and internal organ involvement. IH are clinically diagnosed, and treatment options include active observation, corticosteroids, beta-blockers, pingyangmycin, vincristine, or laser treatment. Complications of untreated IH include ulceration, airway obstruction, and visual obstruction at sites of enlarging lesions. While most cases are benign, there are associated complications prompting a thorough investigation and proper management. Understanding a hemangioma patient's etiology and associated risk factors enables clinicians to treat the condition effectively, preventing adverse outcomes.

This case presents an 86-day-old male born at 34 weeks with no significant past medical history who was referred to the vascular anomalies clinic for multiple infantile hemangiomas. A hemangioma was first noted on his scrotum shortly after birth, followed by the development of 10 additional hemangiomas, allexam, 11 red papules were noted across multiple locations on the body. A liver ultrasound was ordered to rule out internal hemangioma formation due to the presence of multiple hemangiomas (>5), and no signs of hepatic hemangioma formation were observed. The patient was diagnosed with superficial infantile hemangiomas, and the etiology, diagnosis, natural course, and management were discussed with the family. Topical timolol was initiated for treatment of the scrotal hemangioma due to the location and risk of ulceration.

Share

COinS